Related references
Note: Only part of the references are listed.Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
Sheldon M. Singh et al.
CURRENT CARDIOLOGY REPORTS (2015)
Patterns of Initiation of Oral Anticoagulants in Patients with Atrial Fibrillation-Quality and Cost Implications
Nihar R. Desai et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium
Thitima Kongnakorn et al.
CLINICAL DRUG INVESTIGATION (2014)
Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation
Anuraag R. Kansal et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2013)
The Efficacy and Safety of Oral Anticoagulants in Warfarin-Suitable Patients With Nonvalvular Atrial Fibrillation: Systematic Review and Meta-Analysis
Stephen A. Mitchell et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2013)
Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models
Brendan L. Limone et al.
PLOS ONE (2013)
Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Focus on Apixaban
Tatjana S. Potpara et al.
ADVANCES IN THERAPY (2012)
Newer Anticoagulants in Cardiovascular Disease A Systematic Review of the Literature
Abhishek Maan et al.
CARDIOLOGY IN REVIEW (2012)
Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation
William L. Baker et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm et al.
EUROPEAN HEART JOURNAL (2012)
Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation
Gregory Y. H. Lip et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation
Simon Mantha et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Catalogue of EQ-5D Scores for the United Kingdom
Patrick W. Sullivan et al.
MEDICAL DECISION MAKING (2011)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPEAN HEART JOURNAL (2010)
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2009)
Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register
K. M. Mohan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
In-hospital direct cost of acute ischemic and hemorrhagic stroke in Greece
G. Gioldasis et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Update on atrial fibrillation: Part I
Irina Savelieva et al.
CLINICAL CARDIOLOGY (2008)
Costs of atrial fibrillation in five European countries:: results from the Euro Heart Survey on atrial fibrillation
Anna Ringborg et al.
EUROPACE (2008)
The impact of atrial fibrillation on the cost of stroke:: The Berlin acute stroke study
Bernd Brueggenjuergen et al.
VALUE IN HEALTH (2007)
Cost of cardiovascular diseases in the United Kingdom
R. Luengo-Fernandez et al.
HEART (2006)
Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States
Karin S. Coyne et al.
VALUE IN HEALTH (2006)
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Valentin Fuster et al.
CIRCULATION (2006)
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
J Heeringa et al.
EUROPEAN HEART JOURNAL (2006)
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
S Stewart et al.
HEART (2004)
Risk factors for intracerebral hemorrhage in the general population - A systematic review
MJ Ariesen et al.
STROKE (2003)
Probabilistic sensitivity analysis for decision trees with multiple branches: Use of the Dirichlet distribution in a Bayesian framework
AH Briggs et al.
MEDICAL DECISION MAKING (2003)
The economic burden of coronary heart disease in the UK
JLY Liu et al.
HEART (2002)
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study
S Stewart et al.
HEART (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996
S Stewart et al.
EUROPEAN HEART JOURNAL (2001)
The Athens Stroke Registry: Results of a five-year hospital-based study
KN Vemmos et al.
CEREBROVASCULAR DISEASES (2000)